First Patients Treated In Cytori’s Stem & Regenerative Cell Heart Attack Study
Cytori Therapeutics (NASDAQ:CYTX) enrolled the first two patients in a clinical trial using adipose-derived stem and regenerative cells in the treatment of heart attack. In this trial, patients’ cells are made available using Cytori’s Celution? System, a real-time cell processing device. One patient has been enrolled in each trial center, Hospital Universitario Gregorio Marañón in Madrid, Spain, and Thoraxcenter, Erasmus Medical Center in Rotterdam, The Netherlands.
More: continued here
Filed under: Stem Cell Research on February 7th, 2008